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New Variant of 
Rabbit Hemorrhagic 
Disease Virus,  
Portugal, 2012–2013
To the Editor: During November 
2012–February 2013, rabbit hemor-
rhagic disease virus (RHDV) strains 
belonging to the new variant RHDV 
were isolated in Portugal from wild 
European rabbits (Oryctolagus cu-
niculus subsp. algirus). The major 
capsid protein, VP60, of these strains 
was partially characterized. RHDV 
had been previously detected in Por-
tugal in 1989 (1). Before 2011, RHDV 
outbreaks in wild European rabbit (O. 
cuniculus) populations in the Iberian 
Peninsula were exclusively caused by 
strains belonging to genogroup 1 (2,3). 
In the Iberian Peninsula, 2 subspe-
cies of European rabbit are found, O. 
cuniculus subsp. algirus and O. cunic-
ulus subsp. cuniculus. These subspe-
cies are equally susceptible to RHDV 
(3). In 2011, a new variant was iso-
lated in young rabbits belonging to O. 
cuniculus subsp. cuniculus from a rab-
bitry in the province of Navarra, Spain 
(4). The topology of the phylogenetic 
tree that included this variant and the 
susceptibility of kits <2 months old 
suggest that this strain is similar to that 
described in France in 2010 (5).
Before the new variant of RHDV 
emerged and, on the basis of phyloge-
netic relationships, RHDV strains had 
been divided into 6 genogroups (G1–
G6) (1), with strains of G6, or RHD-
Va, having a distinct antigenic profile 
(6). All of these strains replicate in 
the liver and are responsible for caus-
ing death in rabbits >2 months of age. 
Nonpathogenic and weakly patho-
genic RHDV-related strains have also 
been described. The nonpathogenic 
and weakly pathogenic strains are phy-
logenetically distinct from the G1–G6 
strains with ≈20% of nucleotide di-
vergence (7); they typically replicate 
in the intestines (8,9). New variant 
RHDV causes death in kits as young 
as 30 days old and affects vaccinated 
and unvaccinated animals (4). Phylo-
genetically, this new variant falls be-
tween the nonpathogenic groups (4,5).
During November 2012–Feb-
ruary 2013, our laboratory, CIBIO, 
Universidade do Porto, Portugal, re-
ceived liver samples from wild adult 
rabbits and kits, belonging to O. cu-
niculus subsp. algirus, from 3 areas 
of Portugal, Valpaços, Barrancos, and 
Algarve. The rabbits had appeared 
dead and had clinical signs suggesting 
rabbit hemorrhagic disease (RHD). 
We analyzed the samples for RHDV 
by reverse transcription PCR. For this 
process, total RNA was extracted by 
using the RNeasy Mini Kit (QIAGEN, 
Hilden, Germany), according to the 
manufacturer’s instructions. Reverse 
transcription was performed by us-
ing oligo(dT) as primer (Invitrogen, 
Carlsbad, CA, USA) and SuperScript 
III reverse transcription (Invitrogen) 
as recommended by the manufac-
turer. Screening of the samples con-
sisted of PCR with a pair of primers 
as described by Dalton et al. (4). This 
pair amplifies a 738-bp fragment of 
the gene encoding the capsid protein, 
VP60 (PCR conditions are available 
on request). After purification, PCR 
products were sequenced on an au-
tomatic sequencer ABI PRISM 310 
Genetic Analyzer (PE Applied Bio-
systems, Foster City, CA, USA) with 
the same pair of primers.
The virus was detected in 15 sam-
ples, 5 from each locality. The obtained 
sequences were aligned with those 
available from public databases. Re-
trieved sequences represent the RHDV 
groups G1–G6, the nonpathogenic 
groups, and the new variant (GenBank 
accession nos. KF442960–KF442964). 
A phylogenetic tree was inferred in 
MEGA5 (10) by using a maximum-
likelihood (ML) approach. Reliability 
of the nodes was assessed with a boot-
strap resampling procedure consisting 
of 500 replicates of the ML trees. The 
best-fit nucleotide substitution model 
was determined by using MEGA5.
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Our sequences exhibit the highest 
nucleotide sequence identity with the 
RHDV N11 strain from Spain (99%; 
GenBank accession no. JX133161.1), 
which corresponds to the new RHDV 
variant. Thirteen nucleotide substitu-
tions were detected in comparison 
to the Spanish sequence, 3 of which 
were nonsynonymous. The inferred 
ML phylogenetic tree is in agreement 
with those published (1,3,9). G1–G6 
(pathogenic) RHDV strains and non-
pathogenic and weakly pathogenic 
RHDV-related strains (generally re-
ferred to as RCV) form 2 groups 
(Figure). The nonpathogenic strain 
from Australia (RCV-A1_Australia_
MIC-07) does not cluster with other 
nonpathogenic groups and European 
brown hare syndrome virus (EBHSV_
France) appears in a basal position in 
the tree. As described, the new variant 
(N11_Spain) appears between RCV 
and the nonpathogenic Australian 
strain (4,5). The strains isolated from 
rabbits in Portugal cluster with the 
new variant and form a highly sup-
ported group (bootstrap value 1.00). 
These results support the conclusion 
that the virus recovered in Portugal 
belongs to the new variant RHDV de-
scribed in Spain and France.
This  confirms the presence of 
the virus in wild rabbits on the Ibe-
rian Peninsula. We also confirm that 
both European rabbit subspecies are 
susceptible to the new variant. The ap-
pearance and rapid spread of the new 
variant RHDV into the Iberian wild 
rabbit populations raise concern for 
the survival of these populations in 
this region. These conservation con-
cerns are particular highlighted for the 
O. cuniculus subsp. algirus, because it 
only occurs in the southwestern part of 
the Iberian Peninsula, and it is a key 
prey species for several carnivores, 
namely, for the most endangered fe-
line, the Iberian Lynx (Lynx pardinus). 
Therefore, monitoring the spread and 
evolution of this new variant is crucial 
in determining the most appropriate 
conservation measures.
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Figure. Maximum-likelihood phylogenetic tree of 95 partial sequences of the rabbit 
hemorrhagic disease virus (RHDV) capsid gene. Bootstrap values appear next to the nodes 
and are shown only for the major groups: G1–G6 (GenBank accession nos. AB300693, 
AF231353, AF258618, AF453761, AJ006019, AJ302016, AJ303106, AJ495856, 
AJ535092, AJ535094, AJ969628, AM085133, AY269825, AY523410, AY926883, 
AY928268, AY928269, DQ069280, DQ069281, DQ069282, DQ189077, DQ189078, 
DQ205345, DQ280493, DQ530363, DQ841708, EF363035, EF558572, EF558573, 
EF558574, EF558575, EF558576, EF558577, EF558578, EF558581, EF558582, 
EF558583, EF558584, EU003578, EU003579, EU003580, EU003581, EU003582, 
EU250330, EU650679, EU650680, FJ212322, FJ212323, FJ794179, FJ794180, 
FN552800, FR823354, FR823355, GU339228, GU373617, GU373618, GU564448, 
HE963222, HM623309, HQ917923, JF412629, JF438967, JN165233, JN165234, 
JN165235, JN165236, JN851729, JN851730, JN851731, JN851732, JN851733, 
JN851734, JN851735, JQ815391, JQ995154, L48547, M67473, RHU49726, X87607, 
Y15424, Y15427, Z24757, Z29514, Z49271), RCV (GenBank accession nos. GQ166866; 
AM268419; X96868) and new variant RHDV (GenBank accession no. X133161). European 
brown hare syndrome virus (EBHSV) was used to root the tree (GenBank accession no. 
NC_002615). A nonpathogenic strain from Australia was also included (GenBank accession 
no. EU871528). The samples isolated from the rabbits found in Portugal appear in bold 
(Valpaços16_Portugal, Algarve1_Portugal, Algarve3_Portugal, Barrancos7–13_Portugal, 
Barrancos10A-13_Portugal, GenBank accession nos.: KF442960–KF442964. Scale bar 
indicates nucleotide substitutions per site,
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Mycobacterium 
yongonense in  
Pulmonary Disease, 
Italy
To the Editor: Mycobacterium 
yongonense is a recently described 
species (1) that belongs to the M. avi-
um complex (MAC) and is associated 
with pulmonary infection. The strain 
on which the description of species 
was based was isolated in South Ko-
rea from the sputum of a patient with 
unspecified pulmonary disease. We 
describe 2 M. yongonense strains iso-
lated from patients in Italy. 
Patient 1 was a 74-year-old 
woman who had experienced fatigue, 
diarrhea, and weight loss. Her medi-
cal history included liver cirrhosis 
resulting from hepatitis C virus in-
fection and surgery for colon cancer; 
the patient also reported tuberculosis 
in childhood. Chest radiograph re-
vealed a cavitary lesion, a finding con-
firmed by computed tomography scan 
(Figure). Cultures in liquid and solid 
media grew a nonchromogenic my-
cobacterium from sputum and stool 
samples; results were negative for 
urine samples.
The patient was treated with clar-
ithromycin, rifabutin, and ethambutol 
and showed some improvement. A 
bronchoscopic investigation was per-
formed, and microscopic examination 
of bronchoalveolar lavage samples 
revealed the presence of acid-fast 
bacilli that subsequently were grown 
in culture. The patient began improv-
ing markedly starting with the second 
month of treatment, which will be 
continued for a total of 18 months.
Patient 2 was a 74-year-old 
woman, living in a community of 
nuns, who reported cough and dys-
pnea. Her medical history included 
renal failure and surgery for breast 
cancer. A bronchoalveolar lavage 
was performed; samples yielded in 
culture Pseudomonas aeruginosa and 
a nonchromogenic mycobacterium. 
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Letters
Letters commenting on recent arti-
cles as well as letters reporting cases, 
outbreaks, or original research are 
welcome. Letters commenting on ar-
ticles should contain no more than 
300 words and 5 references; they are 
more likely to be published if submit-
ted within 4 weeks of the original ar-
ticle’s publication. Letters reporting 
cases, outbreaks, or original research 
should contain no more than 800 words 
and 10 references. They may have 1 
Figure or Table and should not be divid-
ed into sections. All letters should con-
tain material not previously published 
and include a word count.
